Skip to main content

Advertisement

Advertisement

Business

Moderna sees US$18.4 billion in sales from COVID-19 vaccine in 2021

Moderna sees US$18.4 billion in sales from COVID-19 vaccine in 2021

FILE PHOTO: A detail view of a Moderna COVID-19 vaccine box at a vaccination site at the Esports Stadium Arlington & Expo Center in Arlington, Texas, U.S. February 12, 2021. REUTERS/Cooper Neill

REUTERS: Moderna Inc said on Thursday it was expecting to post US$18.4 billion in sales from its COVID-19 vaccine this year.

Pfizer Inc, which makes the only other vaccine authorized for emergency use in the United States so far, said earlier this month that it was expecting to record sales of about US$15 billion in 2021 from the coronavirus vaccine that it makes with German partner BioNTech.

Moderna also said Chief Medical Officer Tal Zaks would leave the company in late September.

Moderna on Wednesday said it was expecting to produce 700 million doses in 2021, while attempting to scale up production to as much as 1 billion doses.

(Reporting by Manojna Maddipatla and Manas Mishra in Bengaluru; Editing by Anil D'Silva)

Source: Reuters

Advertisement

Also worth reading

Advertisement